Patent ID: 7393845

Claim:
A compound of Formula I wherein X represents O or NR 16 ; Y is —CR 6 R 7 —, —CR 6 R 7 —CR 8 R 9 —, or CO—CR 6 R 7 ; Z represents O; n is 2, 3, 4, 5, 6, 7, 8, 9 or 10; m is 2; A is O or S; W is N; Q is N, C or CH; R 1 -R 3 and R 6 -R 9 are each independently selected from hydrogen, halogen, nitro, cyano, trifluoromethyl, trifluoromethoxy, C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-8 -cycloalkyl, C 3-8 -cycloalkyl-C 1-6 -alkyl, formyl, and acyl; and R 16 is selected from hydrogen, C 1-6 -alkyl, C 3-8 -cycloalkyl, C 3-8 -cycloalkyl-C 1-6 -alkyl, formyl, and acyl; and R 10 and R 11 are each independently selected from hydrogen and C 1-6 -alkyl; and R 12 , R 13 , R 14 and R 15 are each independently selected from hydrogen, halogen, nitro, cyano, trifluoromethyl, trifluoromethoxy, C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-8 -cycloalkyl, C 3-8 -cycloalkyl-C 1-6 -alkyl, aryl, heteroaryl, C 1-6 -alkoxy, C 1-6 -alkylthio, C 1-6 -alkylsulphonyl, hydroxy, formyl, acyl, amino, acylamino, aminocarbonyl, C 1-6 -alkoxycarbonylamino, aminocarbonylamino, C 1-6 -alkylaminocarbonylamino, di(C 1-6 -alkyl)aminocarbonylamino, SO 2 NR 20 R 21 and NR 20 R 21 wherein R 20 and R 21 independently represent hydrogen, C 1-6 -alkyl, C 3-8 -cycloalkyl or phenyl; or R 20 and R 21 together with the nitrogen to which they are attached form a piperidine; any of its enantiomers or any mixture thereof, or a pharmaceutically acceptable acid addition salt thereof.